LeafNLP Demos
Back to explore

Report #2869889

Received Oct 31, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
25 yrs
State
SC
Recovered
Unknown
Vaccinated
Sep 23, 2025
Onset
Sep 23, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK72742—

Symptoms (3)

Exposure during pregnancyProduct use issueWrong product administered

Symptom narrative

pregnant patient received Arexvy instead of Abrysvo; received Arexvy instead of Abrysvo; received Arexvy instead of Abrysvo; This non-serious prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of vaccine exposure during pregnancy in a 25-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 72742, expiry date 12-DEC-2026) for prophylaxis. Co-suspect products included RSV vaccine prot. subunit PreF 2v (Abrysvo) for prophylaxis. On 23-SEP-2025, the patient received Arexvy. The patient did not receive Abrysvo. On 23-SEP-2025, an unknown time after receiving Arexvy, the patient experienced wrong vaccine administered (Verbatim: received Arexvy instead of Abrysvo) and product use in unapproved population (Verbatim: received Arexvy instead of Abrysvo). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: pregnant patient received Arexvy instead of Abrysvo). The outcome of the vaccine exposure during pregnancy, wrong vaccine administered and product use in unapproved population were not applicable. Pregnancy exposure: Pregnancy Exposure (Arexvy): To mother in third trimester Pregnancy Exposure (Abrysvo): To mother in third trimester Estimated Delivery/Due date: 18-NOV-2025 Pregnancy Outcome: Pregnancy was ongoing Additional Information: GSK Receipt Date: 22-OCT-2025 The nurse had reported that a pregnant patient had received Arexvy instead of Abrysvo.; Sender's Comments: US-GSK-US2025137800:SAME REPORTER US-GSK-US2025137805:SAME REPORTER US-GSK-US2025137785:SAME REPORTER US-GSK-US2025137791:SAME REPORTER US-GSK-US2025137807:SAME REPORTER